Skip to content

Released Aug 8, 2018, after the close

10-Q filed Aug 8, 2018, 39 days after period end · 0001144204-18-042893

Q2 2018 · 10-Q
Revenue$3.22M+36.4% vs Q2 2017−9.7% vs Q1 2018
Net Income-$26.81MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$1.30N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$27,166,000N/M
Operating Cash Flowderived-$16,047,000N/M
Free Cash Flowderived-$16,100,000N/M
Margins · derived
Operating margin-844.2%−269.2 pt vs Q2 2017
Net margin-833.0%−256.6 pt vs Q2 2017

What the release said

The release

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2015
Revenue$3.22M$2.36M——
Net Income-$26.81M-$13.60M-$10.15M-$6.94M
EPS Diluted-$1.30-$780.00-$0.59-$0.41

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR